Article Type
Changed
Mon, 05/04/2020 - 15:48
Display Headline
In the Evolving Mystery of BV, an Innovative Oral Treatment Emerges

Click Here to Read the Supplement

Topics include:

  • BV terminology and treatment over time
  • Current understanding of BV etiology
  • BV consequences
  • BV treatments
  • Future research needs in BV

Author:
Steven E. Chavoustie, MD, FACOG, CCRP

University of Miami

Miller School of Medicine

Miami, Florida

 

Click Here to Read the Supplement

Sponsor
This supplement is sponsored by Symbiomix Therapeutics, LLC (a Lupin Company).
Publications
Topics
Sections
Sponsor
This supplement is sponsored by Symbiomix Therapeutics, LLC (a Lupin Company).
Sponsor
This supplement is sponsored by Symbiomix Therapeutics, LLC (a Lupin Company).

Click Here to Read the Supplement

Topics include:

  • BV terminology and treatment over time
  • Current understanding of BV etiology
  • BV consequences
  • BV treatments
  • Future research needs in BV

Author:
Steven E. Chavoustie, MD, FACOG, CCRP

University of Miami

Miller School of Medicine

Miami, Florida

 

Click Here to Read the Supplement

Click Here to Read the Supplement

Topics include:

  • BV terminology and treatment over time
  • Current understanding of BV etiology
  • BV consequences
  • BV treatments
  • Future research needs in BV

Author:
Steven E. Chavoustie, MD, FACOG, CCRP

University of Miami

Miller School of Medicine

Miami, Florida

 

Click Here to Read the Supplement

Publications
Publications
Topics
Article Type
Display Headline
In the Evolving Mystery of BV, an Innovative Oral Treatment Emerges
Display Headline
In the Evolving Mystery of BV, an Innovative Oral Treatment Emerges
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.